Capital Performance Advisors LLP Makes New Investment in Eli Lilly and Company (NYSE:LLY)

Capital Performance Advisors LLP purchased a new position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm purchased 373 shares of the company’s stock, valued at approximately $217,000. Other large investors also […]

Related Keywords

Eli Lilly ,Barclays ,Northern Trust Corp ,Dz Bank ,Goldman Sachs Group ,International Assets Investment Management ,Fisher Asset Management ,Company Dividend Announcement ,Jpmorgan Chase Co ,Company Daily ,Citigroup ,Company Stock Performance ,Capital Performance Advisors ,Morgan Stanley ,Securities Exchange Commission ,Company Profile ,Vanguard Group Inc ,Free Report ,Trust Corp ,Assets Investment Management ,Asset Management ,Company Stock ,Get Free Report ,Company Dividend ,Humalog Mix ,Visit Holdingschannel ,Eli Lilly And Company ,Nyse Lly ,Rally ,Medical ,53245710 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,